Skip to main content
· 7/3/2003

Abbott Laboratories and Central Glass Company, Ltd. v. Baxter Pharmaceutical Products, Inc. And Baxter Health Care Corp.

Citations

  • 334 F.3d 1274
  • 67 U.S.P.Q. 2d (BNA) 1191
  • 2003 U.S. App. LEXIS 13507
  • 2003 WL 21512566

How courts have described this case

Verbatim parenthetical descriptions written by other courts when citing this decision. Ranked by citation-network relevance.

  • noting that “effective amount” has a customary usage meaning an “amount sufficient” for the intended result
  • holding that “a” indicated only one member of the Markush group because the patentee failed to expressly indicate the possible selection of multiple members with qualifying language such as “and mixtures thereof’ or “at least one member of the group”
  • noting that “effective amount” has a customary usage meaning an “amount sufficient” for the intended result
  • “A Markush group is a listing of specified alternatives of a group in a patent claim, typically expressed in the form: a member selected from the group consisting of A, B, and C.”

Source: CourtListener parenthetical corpus (CC0).

Judges: Rader, Gajarsa, Dyk

Read full opinion on CourtListener

Sourced from CourtListener / Free Law Project (CC0).

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.